APA aipamena

Rial, N. S., Zell, J. A., Cohen, A. M., & Gerner, E. W. (2012). Clinical endpoints for developing pharmaceuticals to manage patients with sporadic or genetic risk of colorectal cancer.

Chicago Style aipamena

Rial, Nathaniel S., Jason A. Zell, Alfred M. Cohen, and Eugene W. Gerner. Clinical Endpoints for Developing Pharmaceuticals to Manage Patients With Sporadic or Genetic Risk of Colorectal Cancer. 2012.

MLA aipamena

Rial, Nathaniel S., Jason A. Zell, Alfred M. Cohen, and Eugene W. Gerner. Clinical Endpoints for Developing Pharmaceuticals to Manage Patients With Sporadic or Genetic Risk of Colorectal Cancer. 2012.

Kontuz: berrikusi erreferentzia hauek erabili aurretik.